Yuichi Ando Selected Research

Cancer Pain

1/2018	Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
11/2015	Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
2/2010	[Preparation of standard protocol for cancer pain control and evaluation of its clinical effectiveness].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichi Ando Research Topics

Disease

75	Neoplasms (Cancer) 02/2024 - 02/2002
14	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 11/2008
12	Neutropenia 04/2024 - 01/2005
10	Diarrhea 11/2021 - 02/2002
8	Stomach Neoplasms (Stomach Cancer) 02/2024 - 03/2016
7	Thrombocytopenia (Thrombopenia) 10/2023 - 05/2011
7	Hypertension (High Blood Pressure) 10/2022 - 02/2013
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2004
6	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 10/2014
6	Disease Progression 10/2023 - 06/2005
6	Neoplasm Metastasis (Metastasis) 07/2023 - 02/2002
6	Breast Neoplasms (Breast Cancer) 09/2020 - 10/2015
5	Febrile Neutropenia 01/2024 - 05/2011
5	Exanthema (Rash) 10/2022 - 03/2014
4	Anemia 04/2024 - 04/2014
4	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2005
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 10/2015
4	Nausea 01/2018 - 02/2010
4	Vomiting 01/2018 - 02/2010
4	Ovarian Neoplasms (Ovarian Cancer) 05/2015 - 09/2010
4	Drug-Related Side Effects and Adverse Reactions 12/2014 - 01/2005
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 05/2002
3	Hemorrhage 04/2024 - 05/2013
3	Proteinuria 03/2024 - 12/2015
3	Carcinoma (Carcinomatosis) 10/2022 - 10/2003
3	Melanoma (Melanoma, Malignant) 01/2022 - 02/2016
3	Prostatic Neoplasms (Prostate Cancer) 09/2020 - 11/2002
3	Fever (Fevers) 06/2020 - 11/2014
3	Ascites 07/2019 - 05/2011
3	Cancer Pain 01/2018 - 02/2010
3	Periodontitis 09/2017 - 10/2010
3	Pain (Aches) 01/2015 - 04/2014
3	Periodontal Diseases (Periodontal Disease) 05/2013 - 12/2002
3	Leukopenia 01/2005 - 02/2002
2	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 12/2018
2	Adenocarcinoma 10/2023 - 05/2019
2	Abdominal Pain (Pain, Abdominal) 06/2023 - 10/2015
2	Diabetes Mellitus 04/2023 - 01/2021
2	Infections 10/2022 - 01/2020
2	Tooth Loss 10/2022 - 12/2002
2	Amelanotic Melanoma (Amelanotic Melanomas) 01/2022 - 01/2022
2	Vitiligo 01/2022 - 01/2022
2	Cardiotoxicity 07/2021 - 03/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 03/2017
2	Aggressive Fibromatosis (Desmoid) 11/2020 - 12/2015

Drug/Important Bio-Agent (IBA)

22	Irinotecan (Camptosar)FDA LinkGeneric 02/2024 - 02/2002
12	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 06/2005
12	Immune Checkpoint InhibitorsIBA 01/2024 - 03/2018
12	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2022 - 05/2011
11	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 05/2008
10	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 11/2016
9	Docetaxel (Taxotere)FDA Link 01/2024 - 06/2005
8	Bevacizumab (Avastin)FDA Link 05/2022 - 02/2013
7	Capecitabine (Xeloda)FDA Link 07/2023 - 01/2017
6	NivolumabIBA 02/2024 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2016
6	PlatinumIBA 07/2019 - 02/2014
6	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 03/2016 - 05/2002
5	CreatinineIBA 10/2023 - 02/2011
5	Monoclonal AntibodiesIBA 01/2022 - 02/2013
4	pazopanib FDA Link 01/2024 - 04/2014
4	Trastuzumab (Herceptin)FDA Link 10/2023 - 03/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 06/2014
4	Gemcitabine FDA Link 11/2020 - 02/2016
4	Opioid Analgesics (Opioids)IBA 01/2018 - 02/2010
4	Thalidomide (Thalomid)FDA Link 01/2013 - 02/2002
4	Leucovorin (Folinic Acid)FDA Link 08/2011 - 11/2008
3	RamucirumabIBA 02/2024 - 07/2019
3	pegfilgrastim (Neulasta)FDA Link 01/2024 - 02/2018
3	Phosphotransferases (Kinase)IBA 10/2023 - 04/2014
3	Hemoglobins (Hemoglobin)IBA 04/2023 - 01/2021
3	AntibodiesIBA 01/2022 - 03/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 11/2014
3	Lipase (Acid Lipase)FDA Link 01/2021 - 04/2014
3	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
3	AntiemeticsIBA 01/2018 - 02/2010
3	Transaminases (Aminotransferases)IBA 02/2016 - 03/2014
3	UGT1A1 enzymeIBA 04/2014 - 02/2011
2	Etoposide (VP 16)FDA LinkGeneric 04/2024 - 12/2023
2	SteroidsIBA 10/2023 - 10/2004
2	Pemetrexed (MTA)FDA Link 10/2023 - 01/2017
2	Immunoglobulin G (IgG)IBA 10/2023 - 01/2022
2	EnzymesIBA 06/2023 - 02/2011
2	Formaldehyde (Formol)FDA Link 10/2022 - 02/2015
2	ParaffinIBA 10/2022 - 02/2015
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 04/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2018
2	TabletsIBA 01/2021 - 01/2010
2	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 12/2015

Therapy/Procedure

41	Drug Therapy (Chemotherapy) 02/2024 - 05/2002
19	Therapeutics 02/2024 - 08/2011
5	Drug Tapering 03/2024 - 10/2015
4	Chemoradiotherapy 04/2023 - 01/2018
3	Renal Dialysis (Hemodialysis) 04/2024 - 09/2010
3	Aftercare (After-Treatment) 03/2024 - 01/2020
2	Gastrectomy 07/2023 - 02/2017
2	Radiotherapy 10/2022 - 08/2015
2	Intravenous Infusions 05/2022 - 02/2012
2	Immunotherapy 01/2022 - 07/2019